Trump said you could learn something from this man

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Brett Sandercock net worth and biography

Brett Sandercock Biography and Net Worth

CFO of ResMed

Brett Sandercock is the chief financial officer at ResMed.

Sandercock first joined the medical device company in 1998 as a group accountant and controller. He moved on to the role of VP of treasury and finance in 2004, and he was named CFO in January of 2006.

Earlier in his career, Sandercock worked as a manager of financial accounting and group reporting for Norton Abrasives. He also served in accounting and financial roles at Health Care of Australia, a large private hospital operator.

Starting in 1989 and leading up to his time at Health Care of Australia, Sandercock worked for PricewaterhouseCoopers in Sydney, Australia where he specialized in client audits across manufacturing and distribution, technology, financial services and other industries.

Sandercock received his B.A. in economics from Macquarie University in Sydney, and is a certified chartered accountant.

What is Brett Sandercock's net worth?: The estimated net worth of Brett Sandercock is at least $23.14 million as of October 8th, 2024. Mr. Sandercock owns 95,812 shares of ResMed stock worth more than $23,143,389 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Sandercock may own. Additionally, Mr. Sandercock receives a salary of $933,660.00 as CFO at ResMed. Learn More about Brett Sandercock's net worth.
How old is Brett Sandercock?: Mr. Sandercock is currently 57 years old. There are 5 older executives and no younger executives at ResMed. The oldest executive at ResMed is Dr. Peter C. Farrell A.M., B.E., BE, who is 82 years old. Learn More on Brett Sandercock's age.
What is Brett Sandercock's salary?: As the CFO of ResMed Inc., Mr. Sandercock earns $933,660.00 per year. There are 3 executives that earn more than Mr. Sandercock. The highest earning executive at ResMed is Mr. Michael J. Farrell BE, MBA, SM, CEO & Chairman, who commands a salary of $2,920,000.00 per year. Learn More on Brett Sandercock's salary.
How do I contact Brett Sandercock?: The corporate mailing address for Mr. Sandercock and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected]. Learn More on Brett Sandercock's contact information.
Has Brett Sandercock been buying or selling shares of ResMed?: Over the course of the past ninety days, Brett Sandercock has sold $233,470.00 of ResMed stock. Most recently, Brett Sandercock sold 1,000 shares of the business's stock in a transaction on Tuesday, October 8th. The shares were sold at an average price of $233.47, for a transaction totalling $233,470.00. Following the completion of the sale, the chief financial officer now directly owns 95,812 shares of the company's stock, valued at $22,369,227.64. Learn More on Brett Sandercock's trading history.
Who are ResMed's active insiders?: ResMed's insider roster includes Carol Burt (Director), Jan De Witte (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.
Are insiders buying or selling shares of ResMed?: In the last twelve months, insiders at the medical equipment provider sold shares 27 times. They sold a total of 187,789 shares worth more than $41,061,987.20. The most recent insider tranaction occured on November, 12th when Director Witte Jan De sold 796 shares worth more than $198,052.76. Insiders at ResMed own 0.7% of the company. Learn More about insider trades at ResMed.
Information on this page was last updated on 11/12/2024.

Brett Sandercock Insider Trading History at ResMed

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/8/2024	Sell	1,000	$233.47	$233,470.00	95,812
9/9/2024	Sell	1,000	$246.42	$246,420.00	96,812
8/8/2024	Sell	1,000	$212.16	$212,160.00	89,056
7/8/2024	Sell	1,000	$194.35	$194,350.00	90,056
6/10/2024	Sell	1,000	$209.81	$209,810.00	91,056
11/27/2023	Sell	3,000	$152.62	$457,860.00	92,962
5/9/2023	Sell	3,426	$232.05	$795,003.30	103,516
2/13/2023	Sell	4,000	$215.00	$860,000.00	116,880
11/7/2022	Sell	4,000	$212.02	$848,080.00	106,303
8/10/2022	Sell	2,500	$240.66	$601,650.00	106,426
7/22/2022	Sell	7,500	$235.00	$1,762,500.00	106,426
4/11/2022	Sell	2,500	$247.00	$617,500.00	106,354
3/10/2022	Sell	2,500	$241.29	$603,225.00
2/10/2022	Sell	2,500	$241.86	$604,650.00
1/10/2022	Sell	2,500	$235.00	$587,500.00
12/10/2021	Sell	2,500	$264.92	$662,300.00
11/10/2021	Sell	2,500	$260.58	$651,450.00
10/11/2021	Sell	5,000	$253.37	$1,266,850.00
8/20/2021	Sell	10,736	$281.73	$3,024,653.28	94,979
8/10/2021	Sell	2,500	$278.05	$695,125.00
7/12/2021	Sell	2,500	$248.46	$621,150.00
6/10/2021	Sell	2,500	$212.84	$532,100.00	90,002
5/10/2021	Sell	2,500	$196.00	$490,000.00
4/12/2021	Sell	2,500	$198.47	$496,175.00	94,922
3/10/2021	Sell	2,500	$185.00	$462,500.00	97,422
2/10/2021	Sell	2,500	$201.37	$503,425.00	99,922
1/11/2021	Sell	2,500	$218.70	$546,750.00	100,600
12/10/2020	Sell	2,500	$211.06	$527,650.00	103,100
11/24/2020	Sell	5,000	$211.00	$1,055,000.00	105,600
10/15/2020	Sell	2,500	$176.72	$441,800.00	84,275
9/15/2020	Sell	2,500	$175.49	$438,725.00	86,775
8/17/2020	Sell	2,500	$177.55	$443,875.00	89,275
7/15/2020	Sell	2,500	$196.98	$492,450.00	84,796
6/15/2020	Sell	2,500	$158.79	$396,975.00	87,296
4/15/2020	Sell	2,500	$159.03	$397,575.00	92,211
2/18/2020	Sell	2,500	$176.14	$440,350.00	97,211
1/15/2020	Sell	2,500	$158.43	$396,075.00	99,711
12/16/2019	Sell	2,500	$154.71	$386,775.00	102,211
11/26/2019	Sell	2,500	$147.00	$367,500.00	104,711
10/30/2019	Sell	3,000	$145.95	$437,850.00	72,690
9/30/2019	Sell	3,000	$134.14	$402,420.00	73,145
8/30/2019	Sell	3,000	$139.21	$417,630.00	76,145
7/30/2019	Sell	3,000	$129.14	$387,420.00
7/1/2019	Sell	3,000	$123.17	$369,510.00	76,514
5/30/2019	Sell	3,000	$112.34	$337,020.00
4/30/2019	Sell	3,000	$102.98	$308,940.00	82,390
4/1/2019	Sell	3,000	$104.96	$314,880.00	85,390
2/28/2019	Sell	3,000	$103.00	$309,000.00	88,390
1/30/2019	Sell	3,000	$92.30	$276,900.00	91,390
1/15/2019	Sell	2,000	$114.18	$228,360.00	94,390
12/31/2018	Sell	3,000	$112.50	$337,500.00
12/31/2018	Sell	3,000	$112.50	$337,500.00	96,390
12/17/2018	Sell	2,000	$112.56	$225,120.00	99,390
11/30/2018	Sell	3,000	$110.50	$331,500.00	101,390
11/15/2018	Sell	2,000	$101.44	$202,880.00
10/15/2018	Sell	2,000	$103.16	$206,320.00	71,232
9/17/2018	Sell	2,000	$114.30	$228,600.00	73,232
8/15/2018	Sell	2,000	$107.45	$214,900.00
7/16/2018	Sell	2,000	$109.01	$218,020.00	65,072
6/15/2018	Sell	2,000	$106.76	$213,520.00	67,072
5/15/2018	Sell	2,000	$101.52	$203,040.00	69,072
4/16/2018	Sell	2,000	$99.36	$198,720.00	71,072
3/15/2018	Sell	2,000	$98.53	$197,060.00	73,072
2/15/2018	Sell	2,000	$93.42	$186,840.00	75,072
2/1/2018	Sell	1,250	$100.13	$125,162.50	77,072
1/2/2018	Sell	1,250	$84.99	$106,237.50	78,322
12/1/2017	Sell	1,250	$85.36	$106,700.00	79,572
11/1/2017	Sell	1,250	$84.50	$105,625.00	71,772
10/2/2017	Sell	1,250	$77.05	$96,312.50	64,691
9/1/2017	Sell	1,250	$77.56	$96,950.00	65,941
8/1/2017	Sell	1,250	$77.49	$96,862.50	59,258
7/3/2017	Sell	1,250	$77.44	$96,800.00	60,508
6/1/2017	Sell	1,250	$71.02	$88,775.00
5/1/2017	Sell	1,250	$68.60	$85,750.00	62,783
4/3/2017	Sell	1,250	$71.65	$89,562.50	64,033
3/1/2017	Sell	1,250	$72.48	$90,600.00	65,283
8/11/2016	Sell	35,000	$70.50	$2,467,500.00
2/26/2016	Sell	30,000	$57.61	$1,728,300.00	132,136
2/3/2015	Sell	18,670	$62.82	$1,172,849.40
9/5/2014	Sell	10,000	$52.99	$529,900.00
9/3/2014	Sell	10,000	$53.23	$532,300.00
5/8/2014	Sell	5,000	$50.00	$250,000.00	66,423
5/6/2014	Sell	4,290	$50.00	$214,500.00	71,423
2/12/2014	Sell	10,687	$46.00	$491,602.00	84,215
11/20/2013	Sell	15,000	$51.06	$765,900.00	94,902
8/27/2013	Sell	5,000	$49.00	$245,000.00	109,012
5/8/2013	Sell	28,000	$48.97	$1,371,160.00

Brett Sandercock Buying and Selling Activity at ResMed

ResMed Company Overview

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Today's Range

Now: $241.30

$241.30

$242.52

50 Day Range

MA: $242.10

$231.43

$256.07

2 Week Range

Now: $241.30

$151.95

$260.49

Volume

16,300 shs

Average Volume

1,039,343 shs

Market Capitalization

$35.42 billion

P/E Ratio

31.96

Dividend Yield

0.89%

Beta

0.69

Trump said you could learn something from this man

From Wide Moat Research | Ad

Here’s everything you need to know.

Brett Sandercock Biography and Net Worth

What is Brett Sandercock's net worth?

How old is Brett Sandercock?

What is Brett Sandercock's salary?

How do I contact Brett Sandercock?

Has Brett Sandercock been buying or selling shares of ResMed?

Who are ResMed's active insiders?

Are insiders buying or selling shares of ResMed?